Cefazolin in the treatment of acute lower respiratory tract infections. 1976

D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith

UI MeSH Term Description Entries
D008297 Male Males
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
September 1980, The Journal of antimicrobial chemotherapy,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
April 1974, La Clinica terapeutica,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
January 1987, International journal of clinical pharmacology research,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
January 2002, Medicinski pregled,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
November 2007, La Revue du praticien,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
June 2009, Indian pediatrics,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
December 1992, The Annals of pharmacotherapy,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
February 1969, Lancet (London, England),
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
July 1973, Nursing times,
D C Weiser, and L W Winter, and M O Farber, and T P Bright, and N M Shinwarie, and J W Smith
March 2015, The Cochrane database of systematic reviews,
Copied contents to your clipboard!